Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
Status:
Completed
Trial end date:
2020-08-15
Target enrollment:
Participant gender:
Summary
Effect of Vascepa on Progression of Coronary Atherosclerosis in Persons with Elevated
Triglycerides (200-499) on Statin Therapy. The study is to determine progression rates of low
attenuation plaque under influence of Vascepa as compared to placebo.
Phase:
Phase 4
Details
Lead Sponsor:
Los Angeles Biomedical Research Institute Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center